首页>
外国专利>
Use of lysosomal hydrolase-containing aav vectors for preparation of medicaments for treating lysosomal storage disease
Use of lysosomal hydrolase-containing aav vectors for preparation of medicaments for treating lysosomal storage disease
展开▼
机译:含有溶酶体水解酶的aav载体在制备用于治疗溶酶体贮积病的药物中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The disclosure pertains to methods for treating neurometabolic disorder including lysosomal storage diseases that affect the central nervous system, e.g., Niemann-Pick A disease. The disclosed methods involve contacting an axonal ending of a neuron with a composition containing high titer AAV carrying a therapeutic transgene so that the AAV vector is axonally transported in a retrograde fashion and transgene product is expressed distally to the administration site.
展开▼